Terminology Service for NFDI4Health
All terms in ATC
| Label | Id | Description |
|---|---|---|
| lansoprazole, combinations | A02BC53 | |
| indium (111In) oxinate labelled cells | V09HB01 | |
| Furosemid und Triamteren | C03EB21 | |
| briakinumab | L04AC09 | |
| Abrechnung von Verordnungen im Rahmen der künstlichen Befruchtung | V70DA | |
| canakinumab | L04AC08 | |
| tocilizumab | L04AC07 | |
| Sonstige individuell hergestellte parenterale Lösungen | V70CX | |
| Selen-haltige Zubereitungen | A12CH02 | |
| Furosemid und Amilorid | C03EB31 | |
| Magnesium-haltige Zubereitungen | A12CH01 | |
| guselkumab | L04AC16 | |
| sirukumab | L04AC15 | |
| sarilumab | L04AC14 | |
| ixekizumab | L04AC13 | |
| dixyrazine | N05AB01 | |
| brodalumab | L04AC12 | |
| siltuximab | L04AC11 | |
| niclosamide | P02DA01 | |
| perphenazine | N05AB03 |